55
Participants
Start Date
August 23, 2017
Primary Completion Date
August 1, 2020
Study Completion Date
October 22, 2020
GRASPA
Administration of 1-7 doses of 150 IU/kg IV infusion. (every 2 weeks for a maximum of 4 doses and every 6 weeks for maximum 3 doses).
Rigshospitalet, Hematological department, Copenhagen
Aahus University hospial, hematological department, Aarhus
Aarhus University hospital, Aarhus
Aalborg University Hospital, pediatric department, Aalborg
Rigshospitalet, Child and Adolescent Medicine, Copenhagen
Odense University hospital, pediatric department, Odense
Tallin Childrens Hospital, Tallinn
Tartu University Clinics, Tartu
Childrens Hospital, Helsinki. University Central Hospital, Helsinki
Kuopio University Hospital, Kuopio
University Hospital of Oulu, Oulu
Tampere University Hospital, Tampere
Turku University Hospital, Turku
Vilnius University Children's Hospital, Vilnius
Helse Bergen, Bergen
Oslo Universitetssykehus, Rikshospitalet, Oslo
St Olavs Hospital, Trondheim
Drottning Silvias Barn- och ungdomssjukhus, Gothenburg
Universitetssjukhuset Linköping, Linköping
Skånes Universitets sjukhus, Lund
Astrid Lindgrens Barnsjukhus Karolinska, Stockholm
arn- och Ungdomscentrum Norrlands Universitetssjukhus, Umeå
Akademiska sjukhuset Uppsala, Uppsala
Collaborators (1)
ERYtech Pharma
INDUSTRY
Birgitte Klug Albertsen
OTHER